Delivery Order SPE2DB22D1202-SPE2DB25FUUG8

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,039.90 firm fixed-price delivery order is for the supply of PRIORIX VIALS, a vaccine product. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,174.64 firm fixed-price delivery order is for the supply of PRIORIX vials, a vaccine product. The contract has an ultimate completion date of December 22, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,119.70, is a delivery order for the supply of PRIORIX VIALS. It is a firm-fixed-price contract with a completion date of December 30, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,588.60, is for the delivery of Priorix vials, a vaccine product. This is a firm fixed-price delivery order contract with a completion date of November 6, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,014.62 firm fixed-price contract is for the supply of PRIORIX VIALS, with an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,532.97 firm fixed-price delivery order is for the supply of PRIORIX Vials, a medical product. The contract has an ultimate completion date of February 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,440 firm-fixed-price delivery order is for the supply of PRIORIX vials, a vaccine product. The contract has a period of performance through June 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $18,052.30 firm-fixed-price contract is for the supply of PRIORIX VIALS, a vaccine product. The contract has an ultimate completion date of September 4, 2024. AmerisourceBergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of pharmaceutical and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,029.24 firm fixed-price delivery order is for the supply of PRIORIX VIALS, a vaccine product. The contract has an ultimate completion date of March 28, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,395.00, is for the delivery of PRIORIX VIALS, a medical product. The contract is a Delivery Order under a Firm Fixed Price arrangement, with a period of performance running through May 23, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a significant...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUUG8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,455.54, is for the delivery of PRIORIX VIALS, a vaccine product. It is a firm fixed-price delivery order contract with a period of performance ending on March 5, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.

Generated 6/3/25, 9:52 AM